Neurotrophic Signaling Pathway plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Neurotrophic Signaling Pathway is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The Neurotrophic Signaling Pathway is a critical mechanism governing neuronal survival, development, plasticity, and function. Neurotrophic factors (NTFs) and their receptors play essential roles in maintaining dopaminergic, cholinergic, and motor neurons—cell populations preferentially vulnerable in neurodegenerative diseases like Parkinson's Disease (PD), Alzheimer's Disease (AD), and Amyotrophic Lateral Sclerosis (ALS).
flowchart TD
A[Neurotrophic Factor<br/>BDNF/GDNF/NTF3/NTF4] --> B[Receptor Tyrosine Kinase<br/>TrkA/TrkB/TrkC, GFRα1-4] -->
B --> C[ dimerization & autophosphorylation] -->
C --> D[PI3K/Akt Pathway<br/>Cell Survival] -->
C --> E[RAS/MAPK Pathway<br/>Neurite Outgrowth] -->
C --> F[PLCγ Pathway<br/>Synaptic Plasticity] -->
D --> G[mTOR Activation<br/>Protein Synthesis] -->
D --> H[Bad Phosphorylation<br/>Apoptosis Inhibition] -->
E --> I[ERK1/2 Activation<br/>Gene Expression] -->
E --> J[CREB Phosphorylation<br/>BDNF Expression] -->
F --> K[Calcium Signaling<br/>Synaptic Transmission] -->
G --> L[Axon Guidance<br/>Dendritic Growth] -->
H --> M[Neuronal Survival<br/>Anti-apoptotic] -->
I --> N[Cell Differentiation<br/>Development] -->
J --> O[Synaptic Plasticity<br/>Learning & Memory] -->
K --> P[Long-term Potentiation<br>Cognitive Function]
| Factor | Gene | Primary Receptor | Main Target Neurons | Role in Disease |
|
Neurotrophic Signaling Pathway plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Neurotrophic Signaling Pathway has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Allen SJ, et al. (2013). Neurotrophins and neurodegeneration. Acta Neuropathol. DOI:10.1007/s00401-013-1178-4
- Bathina S, Das UN (2015). Brain-derived neurotrophic factor and Alzheimer's disease. J Alzheimers Dis. DOI:10.3233/JAD-150142
- Ibanez CF, Andressoo JO (2017). Biology of GDNF and its receptors. Cell Tissue Res. DOI:10.1007/s00441-017-2733-6
- Chao MV (2003). Neurotrophins and their receptors. EMBO J. DOI:10.1093/emboj/cdg089
- Huang EJ, Reichardt LF (2003). Trk receptors: roles in neuronal signal transduction. Annu Rev Biochem. DOI:10.1146/annurev.biochem.72.121801.161629
- Nagahara AH, Tuszynski MH (2011). Potential of neurotrophic factors for repair of brain. Nat Rev Neurosci. DOI:10.1038/nrn3119
- Song JH, et al. (2017). Advances in neurotrophic factor therapy for neurodegenerative disorders. Prog Neurobiol. DOI:10.1016/j.pneurobio.2017.06.001
Last updated: 2026-03-03
-----|------|------------------|---------------------|-----------------|
| BDNF | BDNF | TrkB | Cortical, hippocampal neurons | AD, depression, cognitive decline |
| GDNF | GDNF | GFRα1/RET | Dopaminergic, motor neurons | PD, ALS |
| NTF3 | NTF3 | TrkC | Sensory, cholinergic neurons | Peripheral neuropathy |
| NTF4 | NTF4 | TrkB | Motor neurons, some cortical | Less characterized |
Neurotrophic factors bind to specific receptor tyrosine kinases (Trk receptors) or GFRα co-receptors:
- TrkA (NTRK1): Binds NGF, primarily sensory and sympathetic neurons
- TrkB (NTRK2): Binds BDNF and NTF4, widespread in CNS
- TrkC (NTRK3): Binds NTF3, motor and sensory neurons
- GFRα/RET complex: GDNF family ligands signal through this receptor complex
The phosphatidylinositol 3-kinase (PI3K)/Akt pathway is the primary pro-survival signaling cascade:
- Receptor activation recruits PI3K to the membrane
- PIP2 → PIP3 conversion activates Akt (PKB)
- Akt phosphorylates multiple targets:
- Bad: Pro-apoptotic protein inhibition
- mTOR: Protein synthesis and autophagy regulation
- GSK-3β: Tau phosphorylation modulation
- FOXO: Transcription factor regulation
The RAS/RAF/MEK/ERK cascade promotes neuronal differentiation and plasticity:
- RAS activation initiates phosphorylation cascade
- MEK1/2 → ERK1/2 activation
- ERK translocates to nucleus
- CREB phosphorylation drives gene expression
- Results in: neurite outgrowth, synaptic plasticity, long-term memory
Phospholipase C gamma activation leads to:
- PIP2 hydrolysis → DAG + IP3
- IP3 triggers calcium release from ER
- PKC activation via DAG
- Synaptic vesicle release modulation
- Long-term potentiation (LTP) enhancement
Dopaminergic neurons in the substantia nigra pars compacta (SNpc) are dependent on GDNF for survival:
- GDNF and neurturin (NRTN) promote dopaminergic neuron survival
- Intraventricular and intraparenchymal GDNF trials showed mixed results
- Gene therapy approaches (AAV-GDNF, AAV-NRTN) in clinical trials
- BDNF also supports dopaminergic neurons via TrkB
BDNF/TrkB signaling is crucial for cognitive function:
- Reduced BDNF levels in AD patient brains and CSF
- Amyloid-beta disrupts BDNF signaling cascade
- TrkB activation protects against Aβ toxicity
- CREB-mediated gene expression impaired in AD
- BDNF Val66Met polymorphism associated with AD risk
Motor neuron survival depends on neurotrophic support:
- GDNF delivery delays disease progression in models
- BDNF trials showed minimal efficacy in humans
- Combination therapies (BDNF + GDNF) being explored
- Astrocyte GDNF expression provides support
Neurotrophic signaling is dysregulated:
- Reduced BDNF transport and expression
- Mutant huntingtin impairs TrkB signaling
- GDNF provides neuroprotection in models
- Restoration of BDNF signaling as therapeutic target
| Agent |
Target |
Status |
Challenges |
| BDNF |
TrkB |
Preclinical/Phase |
Limited CNS penetration |
| GDNF |
GFRα1/RET |
Phase I-II |
Delivery, stability |
| NRTN (Neurturin) |
GFRα2/RET |
Phase II |
Limited efficacy |
- AAV2-GDNF: Intraparenchymal delivery to putamen (NCT01621581)
- AAV2-NRTN (CERE-120): Substantia nigra delivery
- AAV-TrkB: Enhancing BDNF signaling
- Ex vivo gene therapy: Modified cells secreting NTFs
- TrkB agonists: Novel brain-penetrant compounds
- PDE inhibitors: Enhance cAMP/CREB signaling
- mTOR modulators: Autophagy regulation
flowchart LR
subgraph Therapeutic Approaches
A[Recombinant NTFs] --> D[Receptor Activation] -->
B[Gene Therapy] --> D
C[Small Molecule Agonists] --> D
end
D --> E[PI3K/Akt ↑] -->
D --> F[MAPK/ERK ↑] -->
D --> G[PLCγ ↑] -->
E --> H[Neuronal Survival] -->
F --> I[Synaptic Plasticity)
G --> J[Cognitive Function] -->
H --> K[Disease Modification] -->
I --> K
J --> K
| Biomarker |
Sample |
Significance |
| Pro-BDNF |
Plasma/CSF |
Higher in AD, correlates with progression |
| Mature BDNF |
Serum |
Lower in PD, AD; cognitive correlate |
| GDNF |
Serum |
Variable in PD; source unclear |
| TrkB isoforms |
CSF |
Soluble receptor as biomarker |
- Allen SJ, et al. (2013). Neurotrophins and neurodegeneration. Acta Neuropathol. DOI:10.1007/s00401-013-1178-4
- Bathina S, Das UN (2015). Brain-derived neurotrophic factor and Alzheimer's disease. J Alzheimers Dis. DOI:10.3233/JAD-150142
- Ibanez CF, Andressoo JO (2017). Biology of GDNF and its receptors. Cell Tissue Res. DOI:10.1007/s00441-017-2733-6
- Chao MV (2003). Neurotrophins and their receptors. EMBO J. DOI:10.1093/emboj/cdg089
- Huang EJ, Reichardt LF (2003). Trk receptors: roles in neuronal signal transduction. Annu Rev Biochem. DOI:10.1146/annurev.biochem.72.121801.161629
- Pattarawarapan M, Burgess K (2003). Molecular basis of neurotrophin-receptor interactions. J Med Chem. DOI:10.1021/jm030050j
- Klesse LJ, et al. (1999). Nerve growth factor activates a Ras-dependent protein kinase. Oncogene. DOI:10.1038/sj.onc.1202624
- Encinas M, et al. (2000). Sequential treatment of SH-SY5Y cells with retinoic acid and brain-derived neurotrophic factor. J Biol Chem. DOI:10.1074/jbc.M006385200
- Nagahara AH, Tuszynski MH (2011). Potential of neurotrophic factors for repair of brain. Nat Rev Neurosci. DOI:10.1038/nrn3119
- Song JH, et al. (2017). Advances in neurotrophic factor therapy for neurodegenerative disorders. Prog Neurobiol. DOI:10.1016/j.pneurobio.2017.06.001
Page created: 2026-03-03
Last updated: 2026-03-03
[1] Huang EJ, Reichardt LF. Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci. 2001;24:677-736. PMID:11520916.
[2] Patapoutian A, Reichardt LF. Trk receptors: mediators of neurotrophin action. Curr Opin Neurobiol. 2001;11(3):272-280. PMID:11404465.
🔴 Low Confidence
| Dimension |
Score |
| Supporting Studies |
7 references |
| Replication |
0% |
| Effect Sizes |
25% |
| Contradicting Evidence |
33% |
| Mechanistic Completeness |
50% |
Overall Confidence: 32%